Once Future CEO Could have Taken Teva on a Different Path
14.12.17 | Lilach Baumer, Golan Hazani, and Orr Hirschauge
This site uses cookies to ensure the best viewing experience for our readers.
Pascal Soriot
3 stories about Pascal Soriot
New CEO to Break Teva’s Copaxone Habit
11.09.17 | Sophie Shulman, Dror Reich
Soriot's Teva Appointment Unlikely, Says Activist Investor
06.08.17 | Golan Hazani
Tag does not exist. Please try again.